Sensei Biotherapeutics (NASDAQ:SNSE) Trading Up 0.9% – Here’s Why

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) shares were up 0.9% during trading on Thursday . The stock traded as high as $12.40 and last traded at $9.46. Approximately 247,695 shares traded hands during mid-day trading, an increase of 281% from the average daily volume of 65,094 shares. The stock had previously closed at $9.38.

Analyst Ratings Changes

Several research analysts have recently commented on SNSE shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Sensei Biotherapeutics in a report on Wednesday, October 8th. HC Wainwright downgraded Sensei Biotherapeutics from a “buy” rating to a “neutral” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Sensei Biotherapeutics has an average rating of “Moderate Buy” and an average price target of $55.00.

Sensei Biotherapeutics Price Performance

The company has a market capitalization of $11.92 million, a P/E ratio of -0.44 and a beta of 0.31. The company has a 50 day moving average of $9.72 and a 200-day moving average of $8.33.

Sensei Biotherapeutics (NASDAQ:SNSE) last posted its earnings results on Tuesday, August 5th. The company reported ($3.91) earnings per share (EPS) for the quarter, topping the consensus estimate of ($6.20) by $2.29. Research analysts predict that Sensei Biotherapeutics, Inc. will post -1.17 EPS for the current fiscal year.

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.